Pierre Lestage

2.7k total citations · 1 hit paper
63 papers, 2.2k citations indexed

About

Pierre Lestage is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Pierre Lestage has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 27 papers in Cellular and Molecular Neuroscience and 16 papers in Organic Chemistry. Recurrent topics in Pierre Lestage's work include Neuroscience and Neuropharmacology Research (24 papers), Phenothiazines and Benzothiazines Synthesis and Activities (13 papers) and Receptor Mechanisms and Signaling (11 papers). Pierre Lestage is often cited by papers focused on Neuroscience and Neuropharmacology Research (24 papers), Phenothiazines and Benzothiazines Synthesis and Activities (13 papers) and Receptor Mechanisms and Signaling (11 papers). Pierre Lestage collaborates with scholars based in France, Belgium and Denmark. Pierre Lestage's co-authors include Pierre‐Jean Corringer, Antoine Taly, Jean‐Pierre Changeux, Denis Guédin, Brian Lockhart, Philippe Morain, Pierre Bobillier, Laurence Danober, Bernard Pirotte and Bernard N’Kaoua and has published in prestigious journals such as PLoS ONE, Nature Reviews Drug Discovery and Brain Research.

In The Last Decade

Pierre Lestage

63 papers receiving 2.1k citations

Hit Papers

Nicotinic receptors: allosteric transitions and therapeut... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Lestage France 24 1.2k 690 517 276 254 63 2.2k
Thomas G. Heffner United States 32 1.4k 1.2× 1.7k 2.5× 1.2k 2.2× 301 1.1× 312 1.2× 89 3.8k
Karen L. Marquis United States 24 1.1k 1.0× 1.1k 1.6× 269 0.5× 391 1.4× 217 0.9× 44 2.4k
Erling N. Petersen Sweden 31 1.3k 1.1× 2.0k 2.9× 330 0.6× 268 1.0× 724 2.9× 72 3.5k
Kjell Svensson United States 35 2.0k 1.7× 2.6k 3.8× 441 0.9× 223 0.8× 443 1.7× 134 4.2k
Leonard T. Meltzer United States 26 910 0.8× 1.3k 1.8× 740 1.4× 187 0.7× 319 1.3× 83 2.5k
Kenneth S. Koblan United States 34 1.9k 1.7× 1.3k 1.9× 341 0.7× 224 0.8× 367 1.4× 128 3.9k
Alan A. Boulton Canada 31 1.2k 1.0× 1.6k 2.3× 309 0.6× 333 1.2× 227 0.9× 147 3.4k
Patrick M. Beardsley United States 30 1.2k 1.0× 2.1k 3.0× 169 0.3× 546 2.0× 289 1.1× 111 3.1k
Saul Maayani United States 37 2.5k 2.2× 2.6k 3.7× 318 0.6× 332 1.2× 337 1.3× 114 4.4k
Moshe Rehavi Israel 34 1.3k 1.1× 1.6k 2.4× 133 0.3× 458 1.7× 294 1.2× 123 3.8k

Countries citing papers authored by Pierre Lestage

Since Specialization
Citations

This map shows the geographic impact of Pierre Lestage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Lestage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Lestage more than expected).

Fields of papers citing papers by Pierre Lestage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Lestage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Lestage. The network helps show where Pierre Lestage may publish in the future.

Co-authorship network of co-authors of Pierre Lestage

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Lestage. A scholar is included among the top collaborators of Pierre Lestage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Lestage. Pierre Lestage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bretin, Sylvie, Caroline Louis, Laure Seguin, et al.. (2017). Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors. PLoS ONE. 12(9). e0184429–e0184429. 22 indexed citations
2.
Vandesquille, Matthias, Mathieu Baudonnat, Laurence Decorte, et al.. (2013). Working memory deficits and related disinhibition of the cAMP/PKA/CREB are alleviated by prefrontal α4β2*-nAChRs stimulation in aged mice. Neurobiology of Aging. 34(6). 1599–1609. 39 indexed citations
3.
Danober, Laurence, Carmen Muñoz, Alex Cordi, et al.. (2010). DRUG FOCUS: S 18986: A Positive Allosteric Modulator of AMPA‐Type Glutamate Receptors Pharmacological Profile of a Novel Cognitive Enhancer. CNS Neuroscience & Therapeutics. 16(5). e193–212. 29 indexed citations
4.
Lestage, Pierre, et al.. (2010). Pharmacological modulation of contextual “episodic-like” memory in aged mice. Behavioural Brain Research. 215(2). 255–260. 19 indexed citations
5.
Lestage, Pierre, et al.. (2010). Identification of 9-fluoro substituted (−)-cytisine derivatives as ligands with high affinity for nicotinic receptors. Bioorganic & Medicinal Chemistry Letters. 20(22). 6667–6670. 24 indexed citations
6.
Pirotte, Bernard, Pierre Francotte, Eric Goffin, et al.. (2010). Ring-Fused Thiadiazines as Core Structures for the Development of Potent AMPA Receptor Potentiators. Current Medicinal Chemistry. 17(30). 3575–3582. 20 indexed citations
7.
Lockhart, Brian, et al.. (2008). Preparation and affinity profile of novel nicotinic ligands. Bioorganic & Medicinal Chemistry Letters. 18(6). 2188–2193. 4 indexed citations
8.
Francotte, Pierre, Pascal De Tullio, Tchao Podona, et al.. (2008). Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators. Bioorganic & Medicinal Chemistry. 16(23). 9948–9956. 23 indexed citations
9.
López‐Hernández, Gretchen Y., Andon N. Placzek, Jeffrey S. Thinschmidt, et al.. (2007). Partial agonist and neuromodulatory activity of S 24795 for alpha7 nAChR responses of hippocampal interneurons. Neuropharmacology. 53(1). 134–144. 31 indexed citations
10.
Bordet, Régis, Pierre Lestage, Philippe Bouhours, et al.. (2007). Neuroprotection: Present and future. Therapies. 62(6). 473–476. 2 indexed citations
11.
Lockhart, Brian, et al.. (2007). S18986: A positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures. European Journal of Pharmacology. 561(1-3). 23–31. 18 indexed citations
12.
Bordet, Régis, Pierre Lestage, Philippe Bouhours, et al.. (2007). Des agents neuroprotecteurs au concept de traitement modulateur du cours évolutif des maladies cérébrales. Therapies. 62(6). 463–472. 1 indexed citations
14.
Cordi, Alex, et al.. (2002). Novel quinolinone-phosphonic acid AMPA antagonists devoid of nephrotoxicity. Il Farmaco. 57(10). 787–802. 11 indexed citations
15.
Lockhart, Brian, et al.. (2001). Protective effect of the antioxidant 6-ethoxy-2,2-pentamethylen-1,2-dihydroquinoline (S 33113) in models of cerebral neurodegeneration. European Journal of Pharmacology. 416(1-2). 59–68. 20 indexed citations
18.
Lestage, Pierre, et al.. (1998). Involvement of nicotinergic mechanisms in thyrotropin-releasing hormone-induced neurologic recovery after concussive head injury in the mouse. European Journal of Pharmacology. 357(2-3). 163–169. 5 indexed citations
19.
Vitte, P.A., C. Harthé, Pierre Lestage, Bruno Claustrat, & Pierre Bobillier. (1988). Plasma, Cerebrospinal Fluid, and Brain Distribution of 14C‐Melatonin in Rat: A Biochemical and Autoradiographic Study. Journal of Pineal Research. 5(5). 437–453. 76 indexed citations
20.
Lestage, Pierre, et al.. (1987). An In Vivo Kinetic Model with L‐[35S]Methionine for the Determination of Local Cerebral Rates for Methionine Incorporation into Protein in the Rat. Journal of Neurochemistry. 48(2). 352–363. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026